Primary Cells

Human Chronic Myeloid Leukemia Bone Marrow Plasma (Accelerated/Blast Crisis)

  • For research use only

Cat No.

ABC-TC3360

Product Type

Blood Products

Cell Type

Plasma

Species

Human

Growth Conditions

37 ℃, 5% CO2

Source Organ

Bone Marrow

Disease

Chronic Myeloid Leukemia

Storage

Liquid Nitrogen

Human Chronic Myeloid Leukemia Bone Marrow Plasma (Accelerated/Blast Crisis) provides disease-state plasma for biomarker and translational research.

Product Image

Description

Human Chronic Myeloid Leukemia (CML) Bone Marrow Plasma (Accelerated/Blast Crisis) is collected from the bone marrow aspirates of human donors diagnosed with CML in the accelerated phase or blast crisis phase. The sample type is plasma derived from bone marrow after removal of cells via centrifugation. It contains soluble proteins, cytokines, chemokines, metabolites, and extracellular vesicles secreted by leukemic and stromal cells, reflecting the advanced pathological state of CML. Bone marrow plasma from this disease stage is enriched in inflammatory factors, disease-associated signaling molecules, and often exhibits high levels of BCR-ABL fusion transcript products and blast-associated markers, depending on donor pathology. Each lot undergoes rigorous screening and isolation procedures and is tested to ensure it is free from contamination by HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
Product Code

Human Chronic Myeloid Leukemia Bone Marrow Plasma (Accelerated/Blast Crisis), Human CML Bone Marrow Plasma, Bone Marrow Plasma, Plasma

Species

Human

Cat.No

ABC-TC3360

Product Category

Primary Cells

Size/Quantity

1 vial

Cell Type

Plasma

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Bone Marrow

Disease

Chronic Myeloid Leukemia

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Blood Products

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Application

  • Human Chronic Myeloid Leukemia (CML) Bone Marrow Plasma (Accelerated/Blast Crisis) is a valuable resource for biomarker discovery, proteomic and metabolomic profiling, cytokine quantification, and translational studies of leukemia progression. It supports assay development for diagnostics, therapeutic monitoring, and understanding the microenvironmental changes during CML acceleration and blast transformation. Additionally, it serves as a critical tool for preclinical validation of targeted therapies and resistance mechanisms in advanced-stage CML models.

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Inquiring Human Chronic Myeloid Leukemia Bone Marrow Plasma (Accelerated/Blast Crisis)

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button